2seventy Bio Stock Investor Sentiment

TSVT Stock  USD 3.75  0.14  3.88%   
Slightly above 54% of 2Seventy Bio's private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding 2Seventy Bio suggests that some traders are interested. 2Seventy Bio's investing sentiment can be driven by a variety of factors including economic data, 2Seventy Bio's earnings reports, geopolitical events, and overall market trends.
  

2Seventy Bio Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards 2Seventy Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
few days ago at gurufocus.com         
Insider Sell Marcela Maus Sells 3,900 Shares of 2seventy bio Inc
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Disposition of 9000 shares by Victoria Eatwell of 2Seventy Bio at 13.2 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
few days ago at news.google.com         
2seventy bio, Inc. Reports Q3 Loss, Lags Revenue Estimates - MSN
Google News at Macroaxis
over a week ago at www.macroaxis.com         
Disposition of 00 shares by Maus Marcela V. of 2Seventy Bio at 3.3801 subject to Rule 16b-3
Macroaxis News
over a week ago at simplywall.st         
Analysts Have Been Trimming Their 2seventy bio, Inc. Price Target After Its Latest Report
Simply Wall St News at Macroaxis
over a week ago at finance.yahoo.com         
US8.25 Thats What Analysts Think 2seventy bio, Inc. Is Worth After Its Latest Results
Yahoo News
over a week ago at simplywall.st         
2seventy bio Third Quarter 2024 Earnings EPS Beats Expectations, Revenues Lag
Simply Wall St News at Macroaxis
over a week ago at gurufocus.com         
2seventy bio Inc Q3 2024 Earnings Call Highlights Strong Abecma Growth and Strategic ...
Gurufocus Stories at Macroaxis
over a week ago at insidermonkey.com         
2seventy bio, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over a week ago at seekingalpha.com         
2seventy bio GAAP EPS of -0.19, revenue of 13.53M
seekingalpha News
over a week ago at investing.com         
Goldman Sachs maintains sell on 2Seventy Bio, target 2
Investing News at Macroaxis
over two weeks ago at zacks.com         
Geron Reports Q3 Loss, Tops Revenue Estimates
zacks News
over two weeks ago at gurufocus.com         
Morgan Stanleys Strategic Reduction in 2seventy bio Inc Shares
Gurufocus Stories at Macroaxis
over two weeks ago at news.google.com         
Morgan Stanleys Strategic Reduction in 2seventy bio Inc Shares - GuruFocus.com
Google News at Macroaxis
over two weeks ago at businesswire.com         
2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Con...
businesswire News
Far too much social signal, news, headlines, and media speculation about 2Seventy Bio that are available to investors today. That information is available publicly through 2Seventy media outlets and privately through word of mouth or via 2Seventy internal channels. However, regardless of the origin, that massive amount of 2Seventy data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of 2Seventy Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of 2Seventy Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to 2Seventy Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive 2Seventy Bio alpha.

2Seventy Bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
2seventy bio Provides Update on KarMMa-9 Study and Previews Anticipated Strong Third Quarter Revenue Performance
09/25/2024
2
2seventy bio, Inc. INVESTIGATION Levi Korsinsky Investigates Potential Securities Fraud by 2seventy bio, Inc.
10/02/2024
3
TSVT ALERT- Levi Korsinsky Has Commenced an Investigation on Behalf of 2seventy bio, Inc. Shareholders Who Lost Money
10/07/2024
4
TSVT ACTIVE INVESTIGATION Contact Levi Korsinsky if you Lost Money on Your 2seventy bio, Inc. investment
10/08/2024
5
Strength Seen in Castle Biosciences Can Its 9.4 percent Jump Turn into More Strength
10/15/2024
6
Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings
10/28/2024
7
Geron Reports Q3 Loss, Tops Revenue Estimates
11/07/2024
8
2seventy bio GAAP EPS of -0.19, revenue of 13.53M
11/12/2024
9
2seventy bio Third Quarter 2024 Earnings EPS Beats Expectations, Revenues Lag
11/14/2024
10
Disposition of 00 shares by Maus Marcela V. of 2Seventy Bio at 3.3801 subject to Rule 16b-3
11/18/2024
11
Insider Sell Marcela Maus Sells 3,900 Shares of 2seventy bio Inc
11/21/2024

Additional Tools for 2Seventy Stock Analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.